Elite Pharmaceuticals, Inc. (ELTP)

Elite Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 29, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	743	465	157	29	35	62
Market Cap Growth	76.92%	195.83%	434.24%	-16.81%	-42.59%	1.75%
Enterprise Value	728	468	159	27	31	61
Last Close Price	0.69	0.43	0.15	0.03	0.03	0.06
PE Ratio	-	-	7.81	8.26	3.97	12.10
PS Ratio	7.04	5.53	2.77	0.86	1.10	2.42
PB Ratio	15.57	8.68	2.73	1.01	1.40	3.81
P/TBV Ratio	15.67	8.73	2.74	1.03	1.43	3.92
P/FCF Ratio	41.20	79.70	-	-	5.88	21.50
P/OCF Ratio	38.91	62.33	-	8.81	5.43	19.27
EV/Sales Ratio	6.90	5.56	2.81	0.80	0.96	2.40
EV/EBITDA Ratio	17.60	20.43	13.09	5.25	4.94	17.86
EV/EBIT Ratio	18.64	22.05	14.75	6.92	6.11	28.90
EV/FCF Ratio	40.37	80.19	-	-	5.15	21.24
Debt / Equity Ratio	0.14	0.20	0.20	0.13	0.11	0.15
Debt / EBITDA Ratio	0.16	0.46	0.95	0.73	0.43	0.66
Debt / FCF Ratio	0.37	1.87	-	-	0.46	0.83
Asset Turnover	1.06	0.93	0.91	0.90	1.05	0.99
Inventory Turnover	2.81	3.01	2.69	2.16	2.97	2.95
Quick Ratio	5.39	3.42	2.04	1.40	1.73	1.15
Current Ratio	7.23	4.88	3.07	2.75	2.82	2.10
Return on Equity (ROE)	-20.42%	-7.77%	46.47%	13.15%	43.01%	37.96%
Return on Assets (ROA)	24.50%	14.72%	10.83%	6.52%	10.33%	5.14%
Return on Capital (ROIC)	39.27%	19.82%	13.20%	8.15%	13.62%	7.92%
Return on Capital Employed (ROCE)	38.80%	25.10%	15.30%	12.00%	17.80%	10.30%
Earnings Yield	-1.46%	-0.93%	12.80%	12.11%	25.18%	8.27%
FCF Yield	2.43%	1.26%	-2.57%	-8.15%	17.00%	4.65%
Buyback Yield / Dilution	-2.86%	-4.40%	-1.02%	-0.23%	-7.17%	5.06%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.